Serum vascular endothelial growth factor-C level in patients with colorectal carcinoma and its clinical significance
Jianxiong Chen
Abstract
Jianxiong Chen
Abstract
Objective To measure circulating vascular endothelial growth factor-C(VEGF-C) levels in(patients) with colorectal carcinoma,and assess the clinical significance in diagnosis of lymph node metastasis.Methods Sixty-six patients with colorectal carcinoma and 30 healthy control patients were included in this study.Circulating VEGF-C and VEGF levels were assessed by enzyme-linked immunosorbent assay.Results Serum VEGF-C and VEGF concentration was higher in patients with colorectal carcinoma than in healthy control patients(P0.01).Patients with lymph node metastasis revealed higher serum VEGF-C and VEGF concentrations than those without hymph node metastasis(P0.01).The level of VEGF-C and VEGF in lymphatic vessel invasion and venous invasion was higher in the group with invasion than in the group without invasion(P0.01).Serum VEGF-C levels reached a sensitivity of 81.0% and a specificity of 76.0% with a cutoff value of 1438.0 pg/mL,whereas VEGF levels reached 72.0% sensitivity and(74.0)% specificity at 240.2 pg/mL.With combined determination of VEGF-C and VEGF levels,the(positive) predictive value was 84.6%,the negative predictive value was 94.6%,and accuracy was(93.7)%.Conclusions Circulating VEGF-C levels may provide additional information for distinguishing(between) the absence or presence of lymph node metastasis in patients with colorectal carcinoma.VEGF-C can become a new target spot in the treatment of lymphatic metastasis in patients with colorectal cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To measure circulating vascular endothelial growth factor-C(VEGF-C) levels in(patients) with colorectal carcinoma,and assess the clinical significance in diagnosis of lymph node metastasis.Methods Sixty-six patients with colorectal carcinoma and 30 healthy control patients were included in this study.Circulating VEGF-C and VEGF levels were assessed by enzyme-linked immunosorbent assay.Results Serum VEGF-C and VEGF concentration was higher in patients with colorectal carcinoma than in healthy control patients(P0.01).Patients with lymph node metastasis revealed higher serum VEGF-C and VEGF concentrations than those without hymph node metastasis(P0.01).The level of VEGF-C and VEGF in lymphatic vessel invasion and venous invasion was higher in the group with invasion than in the group without invasion(P0.01).Serum VEGF-C levels reached a sensitivity of 81.0% and a specificity of 76.0% with a cutoff value of 1438.0 pg/mL,whereas VEGF levels reached 72.0% sensitivity and(74.0)% specificity at 240.2 pg/mL.With combined determination of VEGF-C and VEGF levels,the(positive) predictive value was 84.6%,the negative predictive value was 94.6%,and accuracy was(93.7)%.Conclusions Circulating VEGF-C levels may provide additional information for distinguishing(between) the absence or presence of lymph node metastasis in patients with colorectal carcinoma.VEGF-C can become a new target spot in the treatment of lymphatic metastasis in patients with colorectal cancer.
Key concepts: Medicine, Colorectal cancer, Clinical significance, Vascular endothelial growth factor, Internal medicine, Gastroenterology, Metastasis, Vascular endothelial growth factor C